CRISPR Therapeutics AG (CRSP) Cash from Financing Activities (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted Cash from Financing Activities of $7.18 million for Q2 2026, up 218.0% from $2.26 million a year earlier but down 98.8% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Cash from Financing Activities (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at CRISPR Therapeutics AG was $1.01 billion; for FY2025, it was $426.03 million, up 28.3% from FY2024.
- Annual Cash from Financing Activities has increased for three consecutive years, though with a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
- In prior years, CRISPR Therapeutics AG's Cash from Financing Activities was $331.98 million in FY2024 (+429.8%), $62.66 million in FY2023 (+62.4%), $38.59 million in FY2022 (-84.6%) and $250.95 million in FY2021 (-75.3%).
- Quarterly Cash from Financing Activities has run from a low of -$466,000 in Q2 2024 to a high of $591.91 million in Q1 2026 over five years.
- On a year-over-year basis, Cash from Financing Activities increased in three of the last five quarters, with growth averaging 234.8%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q4 2025, with growth of 589.8%; the weakest was Q4 2021, with a decline of 98.5%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $591.91 million (Q1 2026), $116.41 million (Q4 2025) and $296.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | CRISPR Therapeutics AG | 5.35 Bn | 5.35 Bn | - | 7.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.18 Mn |
| Mar 31, 2026 | 591.91 Mn |
| Dec 31, 2025 | 116.41 Mn |
| Sep 30, 2025 | 296.77 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 10.59 Mn |
| Dec 31, 2024 | 16.88 Mn |
| Sep 30, 2024 | 9.64 Mn |
| Jun 30, 2024 | -466,000.00 |
| Mar 31, 2024 | 305.93 Mn |
| Dec 31, 2023 | 38.94 Mn |
| Sep 30, 2023 | 1.56 Mn |
| Jun 30, 2023 | 16.77 Mn |
| Mar 31, 2023 | 5.40 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 15.11 Mn |
| Jun 30, 2022 | 10.35 Mn |
| Mar 31, 2022 | 10.65 Mn |
| Dec 31, 2021 | 6.30 Mn |
| Sep 30, 2021 | 10.21 Mn |
API Access
CRISPR Therapeutics AG Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();